Neba Health, LLC

Neba Health, LLC specializes in electroencephalograph (EEG) systems, which are devices used to record electrical activity in the brain. Their portfolio includes standalone EEG systems like the NEBA Compact EEG System and portable mobile headsets, such as the NEBA® Compact EEG2R Mobile Headset. These devices are designed for clinical and mobile use to enable continuous, non-invasive brainwave monitoring.

Neba Health, LLC is headquartered in the United States. The company’s location is relevant for understanding its regulatory framework, as it operates under U.S. medical device regulations.

Neba Health, LLC’s devices are classified as Class II under FDA regulations. This classification is determined by the level of risk associated with the device, with Class II devices generally requiring special controls in addition to general controls to ensure safety and effectiveness. The classification influences the regulatory pathway and documentation requirements for each device.

Neba Health, LLC’s devices are listed in the FDA’s 510(k) premarket notification database and the Unique Device Identifier (UDI) system. The 510(k) database tracks devices that have undergone a premarket submission process to demonstrate substantial equivalence to a legally marketed predicate device, while the UDI system ensures unique identification for tracking and traceability purposes.